Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$209.01 - $232.56 $41,174 - $45,814
197 Added 1.54%
12,987 $2.84 Million
Q4 2023

Feb 06, 2024

SELL
$197.69 - $227.29 $38,154 - $43,866
-193 Reduced 1.49%
12,790 $2.91 Million
Q3 2023

Oct 10, 2023

SELL
$201.05 - $221.7 $58,505 - $64,514
-291 Reduced 2.19%
12,983 $2.61 Million
Q2 2023

Aug 09, 2023

SELL
$211.93 - $241.33 $83,076 - $94,601
-392 Reduced 2.87%
13,274 $3.2 Million
Q1 2023

May 11, 2023

BUY
$213.32 - $257.83 $19,412 - $23,462
91 Added 0.67%
13,666 $3.14 Million
Q4 2022

Feb 14, 2023

SELL
$203.72 - $248.97 $128,139 - $156,602
-629 Reduced 4.43%
13,575 $3.2 Million
Q3 2022

Nov 09, 2022

BUY
$204.81 - $262.19 $22,938 - $29,365
112 Added 0.79%
14,204 $2.91 Million
Q2 2022

Aug 15, 2022

SELL
$213.86 - $277.87 $30,368 - $39,457
-142 Reduced 1.0%
14,092 $3.3 Million
Q1 2022

May 17, 2022

BUY
$259.82 - $298.18 $75,347 - $86,472
290 Added 2.08%
14,234 $3.75 Million
Q4 2021

Feb 10, 2022

SELL
$271.6 - $314.21 $39,653 - $45,874
-146 Reduced 1.04%
13,944 $4.38 Million
Q3 2021

Nov 03, 2021

BUY
$274.82 - $308.34 $141,532 - $158,795
515 Added 3.79%
14,090 $3.97 Million
Q2 2021

Aug 10, 2021

BUY
$251.87 - $278.14 $105,533 - $116,540
419 Added 3.18%
13,575 $3.75 Million
Q1 2021

May 12, 2021

BUY
$204.88 - $255.03 $136,859 - $170,360
668 Added 5.35%
13,156 $3.36 Million
Q4 2020

Feb 11, 2021

BUY
$186.91 - $214.42 $62,801 - $72,045
336 Added 2.76%
12,488 $2.54 Million
Q3 2020

Nov 13, 2020

BUY
$167.03 - $201.3 $143,311 - $172,715
858 Added 7.6%
12,152 $2.29 Million
Q2 2020

Aug 11, 2020

BUY
$113.31 - $182.44 $494,711 - $796,533
4,366 Added 63.02%
11,294 $1.88 Million
Q1 2020

May 11, 2020

BUY
$104.32 - $195.28 $184,646 - $345,645
1,770 Added 34.32%
6,928 $876,000
Q4 2019

Feb 13, 2020

BUY
$163.48 - $173.61 $52,313 - $55,555
320 Added 6.61%
5,158 $873,000
Q3 2019

Nov 08, 2019

BUY
$159.77 - $178.1 $9,266 - $10,329
58 Added 1.21%
4,838 $813,000
Q2 2019

Aug 06, 2019

BUY
$144.16 - $172.9 $32,147 - $38,556
223 Added 4.89%
4,780 $826,000
Q1 2019

May 09, 2019

BUY
$123.7 - $156.3 $161,675 - $204,284
1,307 Added 40.22%
4,557 $697,000
Q4 2018

Feb 08, 2019

SELL
$120.82 - $174.09 $12,082 - $17,409
-100 Reduced 2.99%
3,250 $411,000
Q3 2018

Nov 08, 2018

SELL
$167.67 - $188.27 $1,676 - $1,882
-10 Reduced 0.3%
3,350 $582,000
Q2 2018

Aug 07, 2018

BUY
$160.33 - $189.41 $6,252 - $7,386
39 Added 1.17%
3,360 $603,000
Q1 2018

May 04, 2018

SELL
$161.53 - $178.11 $4,361 - $4,808
-27 Reduced 0.81%
3,321 $537,000
Q4 2017

Feb 02, 2018

BUY
$147.99 - $163.95 $18,054 - $20,001
122 Added 3.78%
3,348 $534,000
Q3 2017

Oct 27, 2017

BUY
$149.47 - $160.56 $482,190 - $517,966
3,226
3,226 $487,000

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $20.7B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Linscomb & Williams, Inc. Portfolio

Follow Linscomb & Williams, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Linscomb & Williams, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Linscomb & Williams, Inc. with notifications on news.